The latest quarterly R&D expense is $2.53 Million with a QoQ Growth of +28.08%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $2.53M.
$2.53M
$2.53 Million
Q2 FY2026 · 2026-06-30
+28.08%
vs. $1.97M prior quarter
20
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $2.53M | +28.08% | +73.56% |
| Q1 FY2026Period end 2026-03-31 | $1.97M | +62.39% | +118.01% |
| Q4 FY2025Period end 2025-12-31 | $1.22M | +11.67% | +45.68% |
| Q3 FY2025Period end 2025-09-30 | $1.09M | -25.27% | +39.85% |
| Q2 FY2025Period end 2025-06-30 | $1.46M | +60.88% | +45.45% |
| Q1 FY2025Period end 2025-03-31 | $905.00K | +8.51% | -22.78% |
| Q4 FY2024Period end 2024-12-31 | $834.00K | +7.20% | -39.70% |
| Q3 FY2024Period end 2024-09-30 | $778.00K | -22.28% | +39.68% |
| Q2 FY2024Period end 2024-06-30 | $1.00M | -14.59% | +15.19% |
| Q1 FY2024Period end 2024-03-31 | $1.17M | -15.26% | -26.34% |
| Q4 FY2023Period end 2023-12-31 | $1.38M | +148.29% | -33.67% |
| Q3 FY2023Period end 2023-09-30 | $557.00K | -35.90% | -67.67% |
| Q2 FY2023Period end 2023-06-30 | $869.00K | -45.38% | -66.79% |
| Q1 FY2023Period end 2023-03-31 | $1.59M | -23.69% | -29.97% |
| Q4 FY2022Period end 2022-12-31 | $2.08M | +21.01% | -38.24% |
| Q3 FY2022Period end 2022-09-30 | $1.72M | -34.16% | -24.73% |
| Q2 FY2022Period end 2022-06-30 | $2.62M | +15.18% | N/A |
| Q1 FY2022Period end 2022-03-31 | $2.27M | -32.70% | N/A |
| Q4 FY2021Period end 2021-12-31 | $3.38M | +47.49% | N/A |
| Q3 FY2021Period end 2021-09-30 | $2.29M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
